MapLight Therapeutics, Inc.
General ticker "MPLT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $906.3M (TTM average)
MapLight Therapeutics, Inc. follows the US Stock Market performance with the rate: 0.7%.
Estimated limits based on current volatility of 6.7%: low 6.24$, high 7.13$
Short-term MPLT quotes
Long-term MPLT plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $57.28MM | $82.95MM | $169.08MM |
| Operating Income | $-57.28MM | $-82.95MM | $-169.08MM |
| Non-Operating Income | $1.57MM | $5.37MM | $7.93MM |
| R&D Expense | $49.12MM | $67.82MM | $137.77MM |
| Income(Loss) | $-55.71MM | $-77.58MM | $-161.15MM |
| Net Income(Loss)* | $-55.71MM | $-77.58MM | $-161.15MM |
| Stockholders Equity | $71.28MM | $115.19MM | $458.37MM |
| Assets | $91.41MM | $136.92MM | $479.51MM |
| Operating Cash Flow | $-52.01MM | $-78.81MM | $-138.14MM |
| Capital expenditure | $0.46MM | $0.77MM | $0.47MM |
| Investing Cash Flow | $-0.46MM | $-80.79MM | $-323.21MM |
| Financing Cash Flow | $104.57MM | $118.06MM | $469.82MM |
| Earnings Per Share** | $-1.34 | $-1.87 | $-3.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.